Technology

OraSure Technologies

$13.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.33 (+2.44%) Today
+$0.05 (+0.36%) As of 10:17 AM UTC after-hours

Why Robinhood?

You can buy or sell OSUR and other stocks, options, and ETFs commission-free!

About OSUR

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA. The listed name for OSUR is OraSure Technologies, Inc. Common Stock.

CEO
Stephen S. Tang
Employees
472
Headquarters
Bethlehem, Pennsylvania
Founded
2000
Market Cap
979.50M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.05M
High Today
$13.93
Low Today
$13.36
Open Price
$13.45
Volume
655.38K
52 Week High
$19.75
52 Week Low
$5.23

Collections

OSUR Earnings

-$0.16
-$0.04
$0.09
$0.21
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 17, After Hours

You May Also Like

CNRG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure